BioLife Solutions DEF 14A: Executive Compensation Details

TL;DR

BioLife Solutions DEF 14A out: Exec comp details for 2023 are in, showing equity awards for PEOs and Non-PEOs.

AI Summary

BioLife Solutions Inc. filed a DEF 14A on June 5, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-principal executive officers (Non-PEO), with specific details on the year-end fair value of outstanding and unvested awards, and the value of vested awards.

Why It Matters

This filing provides transparency into how BioLife Solutions compensates its top executives, which can influence investor perception and employee morale.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing disclosing executive compensation, which typically carries low risk.

Key Players & Entities

• BIOLIFE SOLUTIONS INC (company) — Filer
• 0001628280-24-026862 (filing_id) — Accession Number
• 20231231 (date) — Fiscal Year End
• 20240605 (date) — Filing Date

FAQ

Key Financial Figures

• $0.01 — owned shares of common stock, par value $0.01 per share (the "Common Stock"), of BioL
• $15,000 — fee for such services is approximately $15,000 plus expenses. If we do elect to retain

Filing Documents

• blfs-20240605.htm (DEF 14A) — 1038KB
• blfs-20240605_g1.jpg (GRAPHIC) — 6KB
• blfs-20240605_g2.jpg (GRAPHIC) — 104KB
• blfs-20240605_g3.jpg (GRAPHIC) — 119KB
• blfs-20240605_g4.jpg (GRAPHIC) — 107KB
• blfs-20240605_g5.jpg (GRAPHIC) — 191KB
• 0001628280-24-026862.txt ( ) — 2905KB
• blfs-20240605.xsd (EX-101.SCH) — 1KB
• blfs-20240605_htm.xml (XML) — 89KB

From the Filing

blfs-20240605 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under Rule 14a-12 BIOLIFE SOLUTIONS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): x No fee required. o Fee paid previously with preliminary materials o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Table of Contents June 5, 2024 Dear Stockholder: You are cordially invited to attend BioLife Solutions, Inc.'s 2024 Annual Meeting of Stockholders (the "Annual Meeting") to be held on August 1, 2024 at 9:00 a.m. Pacific Time. The formal meeting notice and proxy statement for the Annual Meeting are attached. The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the Annual Meeting online, vote and submit your questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/BLFS2024. We are pleased to utilize the virtual stockholder meeting technology to provide ready access and cost savings for our stockholders and the company. The virtual meeting format allows attendance from any location in the world. Even if you are planning on attending the Annual Meeting online, please promptly submit your proxy vote by Internet, by telephone, or, if you received a printed form of proxy in the mail, by completing, dating, signing and returning the enclosed proxy, so your shares will be represented at the Annual Meeting. Instructions on voting your shares are on the Notice of Internet Availability of Proxy Materials you received for the Annual Meeting. Internet voting facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m. Eastern Daylight Time on July 31, 2024. If you attend the Annual Meeting online and wish to vote at the Annual Meeting, you will be able to do so even if you have previously returned your proxy card. Thank you for your continued support of and interest in BioLife Solutions, Inc. Sincerely, /s/ Roderick de Greef Roderick de Greef Chief Executive Officer and Chairman of the Board Bothell, Washington June 5, 2024 YOUR VOTE IS IMPORTANT TO ASSURE YOUR REPRESENTATION AT THE ANNUAL MEETING WHETHER OR NOT YOU ATTEND ONLINE, PLEASE CAST YOUR VOTE AS INSTRUCTED IN THE NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS AS PROMPTLY AS POSSIBLE. YOUR PROXY, GIVEN BY VOTING PRIOR TO THE ANNUAL MEETING, MAY BE REVOKED PRIOR TO ITS EXERCISE BY ENTERING A NEW VOTE OVER THE INTERNET OR BY TELEPHONE BY FILING WITH OUR CORPORATE SECRETARY PRIOR TO THE ANNUAL MEETING A WRITTEN NOTICE OF REVOCATION OR A DULY EXECUTED PROXY BEARING A LATER DATE, OR BY ATTENDING THE ANNUAL MEETING ONLINE AND VOTING ONLINE. IF YOU HAVE ALREADY VOTED OR DELIVERED YOUR PROXY FOR THE ANNUAL MEETING, YOUR VOTE WILL BE COUNTED, AND YOU DO NOT HAVE TO VOTE YOUR SHARES AGAIN. ANY STOCKHOLDER ATTENDING THE ANNUAL MEETING ONLINE MAY VOTE EVEN IF HE OR SHE HAS RETURNED A PROXY. IF YOU HAVE CHOSEN TO RECEIVE PAPER COPIES OF YOUR PROXY MATERIALS, INCLUDING THE PROXY CARD, PLEASE COMPLETE, SIGN, DATE AND RETURN THE PROXY CARD AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE RETURN ENVELOPE PROVIDED. Table of Contents BIOLIFE SOLUTIONS, INC. 3303 Monte Villa Parkway, Suite 310 Bothell, Washington 98021 (425) 402-1400 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS THURSDAY, AUGUST 1, 2024 9:00 A.M. PACIFIC TIME TO OUR STOCKHOLDERS : NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of BioLife Solutions, Inc., a Delaware corporation ("we," "us," "our" or the "Company"), will be held on August 1, 2024, at 9:00 a.m. Pacific Time, as a virtual meeting. You will be able to attend, vote your shares, and submit questions during the Annual Meeting via a live webcast available at www.virtualshareholdermeeting.com/BLFS2024. The Annual Meeting will be held for the following purposes, as more fully described in the proxy statement accompanying this notice: 1. ELECTION OF DIRECTORS . To elect the five (5) directors named in the attached proxy statement to serve until his/her successor is duly elected and qualified, unless he/she resigns, is removed or otherwise is disqualified from serving as a director of the Company; 2. APPROVAL ON AN ADVISORY BASIS OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS . To approve on a non-bin

View Full Filing

View this DEF 14A filing on SEC EDGAR